QNRX News and Press, Quoin Pharmaceuticals Ltd. From 10/18/22

Are These Penny Stocks To Buy Right Now Or Avoid Entirely? This article will discuss penny stocks to buy. Specifically, the “to buy” part is based on several Wall Street analysts. It’s also a continuation of our article 3 Penny Stocks With 1,000% Upside Potential ...

Quoin Pharmaceuticals ( NASDAQ: QNRX ) stock rose ~22% on Tuesday after the company said it was starting a second trial in patients with Netherton Syndrome (NS). NS is a rare genetic disorder characterized by scaling skin, hair issues, and increased susce...

ASHBURN, Va., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, announces that it is initiating a second clinical trial in Netherton Synd...

Penny stocks are some of the most volatile types of stocks out there. This article looks at a handful of cheap stocks to watch as the stock market crash continues. Why would anyone want to take on so much risk during times like these? The simple answer is capitalizing on volatility. The S&a...

ASHBURN, Va., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, has established a patient specific website: https://www.nethertonsyn...

Penny stocks are some of the riskiest asset classes in the stock market today. Trading these cheap stocks isn’t for the timid. However, if you can learn how to trade correctly, volatility could be the thing you look for to make money in the stock market. Today we look at a handful of...

Quoin Pharmaceuticals, Ltd. (QNRX) Q2 2022 Earnings Conference Call August 18, 2022 08:30 AM ET Company Participants Gordon Dunn - Chief Financial Officer Michael Myers - Chief Executive Officer Denise Carter - Chief Operating Officer and Director Conferenc...

Blue Water Vaccines ( BWV ) -30% . Eargo ( EAR ) -14% erasing yesterday's gain following FDA clearing over-the-counter hearing aid sales . Accelerate Diagnostics ( AXDX ) -13% on proposed public offering of common stock . Histogen ( HSTO ) ...

Quoin Pharmaceuticals press release ( NASDAQ: QNRX ): Q2 GAAP EPS of -$3.24. Quoin ended the second quarter with approximately $2.7 million in cash. Shares -5% PM. For further details see: Quoin Pharmaceuticals GAAP EPS of -$3.24

Initiates clinical trial evaluating lead product candidate, QRX003 for Netherton Syndrome Expands number of commercial partnerships to eight, covering 60 countries Signs Research Agreement to develop a product for the treatment of scleroderma Closes $16.8 million public ...